Evaluation of Emerging Antimicrobials, 2nd Edition
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Novel Antimicrobial Agents".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 104
Special Issue Editor
Interests: drug design and synthesis; chemistry; cancer; infectious diseases; pharmacology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The first edition of the Special Issue “Evaluation of Emerging Antimicrobials” was closed in the first half of 2025, and can be found at the following link: https://www.mdpi.com/journal/antibiotics/special_issues/LR6JHE8B36.
It focused on antimicrobial agents in the treatment and prevention of infections, and its success has encouraged us to launch a second edition on the same topic. As a continuation of the first Special Issue, we aim to present new chemical agents (NCEs) and their antimicrobial evaluation against different microorganisms. It also encourages any novel advances in the mechanistic insights of known antimicrobial agents toward infections. We welcome research articles and reviews, including discussions of antimicrobial therapy, clinical strategies, and new antimicrobial agent discovery.
Dr. Dilep Kumar Sigalapalli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibacterials
- antibiotics
- antifungals
- antimicrobial agents
- antimicrobial resistance
- antivirals
- bacterial resistance
- infections
- multidrug resistance
- pathogens
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issue
- Evaluation of Emerging Antimicrobials in Antibiotics (4 articles)
